Fanny Polesso

1.2k total citations · 1 hit paper
17 papers, 855 citations indexed

About

Fanny Polesso is a scholar working on Immunology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fanny Polesso has authored 17 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 9 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fanny Polesso's work include Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Fanny Polesso is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Fanny Polesso collaborates with scholars based in United States, Netherlands and France. Fanny Polesso's co-authors include Amy E. Moran, Mike J. Mason, Michael T. McManus, Eran Meshorer, Adi Alajem, João Ramalho‐Santos, Amy Heidersbach, Rupa Sridharan, Kathrin Plath and Miguel Ramalho‐Santos and has published in prestigious journals such as Nature, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Fanny Polesso

15 papers receiving 847 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Androgen receptor activity in T cells limits checkpoint blockade efficacy

2022 233 citations Xiangnan Guan, Fanny Polesso et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fanny Polesso United States	9	469	286	273	108	103	17	855
Shawn P. Fahl United States	13	409 0.9×	436 1.5×	245 0.9×	25 0.2×	121 1.2×	20	859
Karen E. Strunk United States	10	339 0.7×	215 0.8×	219 0.8×	51 0.5×	51 0.5×	11	657
Mark A. Zarnegar United States	8	487 1.0×	216 0.8×	150 0.5×	140 1.3×	64 0.6×	9	740
Valeria Mollica Poeta Italy	6	243 0.5×	391 1.4×	395 1.4×	84 0.8×	84 0.8×	7	755
Yizhou Huang China	14	637 1.4×	127 0.4×	117 0.4×	38 0.4×	225 2.2×	35	880
Alexandros Strikoudis United States	13	587 1.3×	87 0.3×	184 0.7×	188 1.7×	68 0.7×	13	887
Xingjiang Yu China	14	479 1.0×	229 0.8×	148 0.5×	60 0.6×	174 1.7×	29	801
Vishnu Hosur United States	14	312 0.7×	130 0.5×	152 0.6×	31 0.3×	71 0.7×	25	608
Chikai Zhou Sweden	13	547 1.2×	161 0.6×	86 0.3×	31 0.3×	51 0.5×	18	742

Countries citing papers authored by Fanny Polesso

Since Specialization

Citations

This map shows the geographic impact of Fanny Polesso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanny Polesso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanny Polesso more than expected).

Fields of papers citing papers by Fanny Polesso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanny Polesso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanny Polesso. The network helps show where Fanny Polesso may publish in the future.

Co-authorship network of co-authors of Fanny Polesso

This figure shows the co-authorship network connecting the top 25 collaborators of Fanny Polesso. A scholar is included among the top collaborators of Fanny Polesso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanny Polesso. Fanny Polesso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Chesner, Lisa N., Julie N. Graff, Fanny Polesso, et al.. (2023). Abstract B041: AR suppresses MHC Class I expression and T-cell response in prostate cancer. Cancer Research. 83(11_Supplement). B041–B041. 2 indexed citations

Polesso, Fanny, et al.. (2023). Abstract NG01: Dendritic cell intrinsic androgen receptor signaling reduces dendritic cell function and anti-tumor immunity. Cancer Research. 83(7_Supplement). NG01–NG01. 2 indexed citations

Guan, Xiangnan, Fanny Polesso, Chaojie Wang, et al.. (2022). Androgen receptor activity in T cells limits checkpoint blockade efficacy. Nature. 606(7915). 791–796. 233 indexed citations breakdown →

Polesso, Fanny, Breanna Caruso, Scott A. Hammond, & Amy E. Moran. (2022). Restored Thymic Output after Androgen Blockade Participates in Antitumor Immunity. The Journal of Immunology. 210(4). 496–503. 6 indexed citations

Polesso, Fanny, et al.. (2022). Abstract 661: Androgen deprivation therapy allows for effective anti-TIGIT immunotherapy in murine model of castration resistant prostate cancer. Cancer Research. 82(12_Supplement). 661–661.

Hawkins, Reed M., Fanny Polesso, & Amy E. Moran. (2022). Androgen receptor regulation of CD8 T cell immune responses. The Journal of Immunology. 208(Supplement_1). 55.21–55.21.

Polesso, Fanny, et al.. (2021). PD‐1‐specific “Blocking” antibodies that deplete PD‐1 ⁺ T cells present an inconvenient variable in preclinical immunotherapy experiments. European Journal of Immunology. 51(6). 1473–1481. 15 indexed citations

Polesso, Fanny, et al.. (2019). OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function. The Journal of Immunology. 203(7). 2011–2019. 27 indexed citations

Polesso, Fanny, Andrew D. Weinberg, & Amy E. Moran. (2018). Late-Stage Tumor Regression after PD-L1 Blockade Plus a Concurrent OX40 Agonist. Cancer Immunology Research. 7(2). 269–281. 37 indexed citations

10.

Polesso, Fanny, et al.. (2017). Constitutive expression of NF-κB inducing kinase in regulatory T cells impairs suppressive function and promotes instability and pro-inflammatory cytokine production. Scientific Reports. 7(1). 14779–14779. 24 indexed citations

11.

Moran, Amy E., Fanny Polesso, & Andrew D. Weinberg. (2016). Immunotherapy Expands and Maintains the Function of High-Affinity Tumor-Infiltrating CD8 T Cells In Situ. The Journal of Immunology. 197(6). 2509–2521. 28 indexed citations

12.

Tucker, Christopher, et al.. (2015). Comparison of anti-OX40 to PD-1 and CTLA-4 blockade in T cell immunization/priming models (TUM3P.1047). The Journal of Immunology. 194(1_Supplement). 70.4–70.4. 2 indexed citations

13.

Moran, Amy E., Fanny Polesso, & Andrew D. Weinberg. (2014). OX40 agonist immunotherapy expands tumor reactive CD8 T cells with a unique T cell receptor repertoire and synergizes with PDL-1 blockade to promote tumor regression. Journal for ImmunoTherapy of Cancer. 2(S3). 2 indexed citations

14.

Murray, Susan, Fanny Polesso, Alexander M. Rowe, et al.. (2011). NF-κB–inducing kinase plays an essential T cell–intrinsic role in graft-versus-host disease and lethal autoimmunity in mice. Journal of Clinical Investigation. 121(12). 4775–4786. 58 indexed citations

15.

Polesso, Fanny, Susan Murray, Alexander M. Rowe, & David Parker. (2011). NIK overexpression intrinsically inhibits regulatory T cell function (168.9). The Journal of Immunology. 186(1_Supplement). 168.9–168.9. 1 indexed citations

16.

Gaspar‐Maia, Alexandre, Adi Alajem, Fanny Polesso, et al.. (2009). Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature. 460(7257). 863–868. 387 indexed citations

17.

Horst, Edward H. van der, Brendon Frank, Lawrence Chinn, et al.. (2008). The Growth Factor Midkine Antagonizes VEGF Signaling In Vitro and In Vivo. Neoplasia. 10(4). 340–IN3. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact